Attain Command™ + SureValve™ 6250V-MPX (UDI 00643169142848)Recalls & reported problems
Medtronic, Inc. · Catheter 6250V-MPX Attain Command · Class 2
All models of Attain Command + SureValve (17)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169142848), received between Feb 8, 2018 and Feb 19, 2021 — classified as 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Pericardial Effusion2
- Cardiac Perforation1
- Vascular Dissection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryFeb 19, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING THE IMPLANT PROCEDURE, WHILE ATTEMPTING TO DELIVER THE LEFT VENTRICULAR (LV) LEAD INTO THE DISTAL BRANCH OF THE CORONARY SINUS, THE CATHETER CAUSED A PERFORATION. A SMALL PERICARDIAL EFFUSION WAS NOTED UNDER ULTRASOUND. NO PERICARDIOCENTESIS WAS REQUIRED. THE LV LEAD IMPLANT WAS ABANDONED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Cardiac Perforation; Pericardial Effusion
MAUDE report 11348622 ↗InjuryFeb 8, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE DELIVERY CATHETER CAUSED A CORONARY SINUS DISSECTION AS WELL AS INFILTRATION OF THE EPICARDIAL FAT WITH SUBSEQUENT PERICARDIAL EFFUSION. THE PATIENT WAS MONITORED WITH NO CHANGE IN HEMODYNAMICS. A CHEST X-RAY THE FOLLOWING DAY APPEARED NORMAL AND THE PATIENT WAS DISCHARGED. THE PATIENT IS A PARTICIPANT IN THE ATTAIN STABILITY QUAD CLINICAL STUDY. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Pericardial Effusion; Vascular Dissection
MAUDE report 7257947 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page